| Trial ID: | L2959 |
| Source ID: | NCT00946504
|
| Associated Drug: |
Glipizide 10 Mg Tablets (Geneva Pharmaceutical, Inc.)
|
| Title: |
To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.)|DRUG: Glucotrol 10 mg Tablets (Roerig Pharmaceutical, Inc.)
|
| Outcome Measures: |
Primary: Bioequivalence based on AUC and Cmax, 9 days |
|
| Sponsor/Collaborators: |
Sponsor: Sandoz
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
1992-10
|
| Completion Date: |
1992-10
|
| Results First Posted: |
|
| Last Update Posted: |
2017-03-28
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00946504
|
